Dr. Yan Jiao, Ph.D., is a doctor in the Department of Hepatobiliary and Pancreatic Surgery at the First Hospital of Jilin University, where he also serves as an active clinical researcher specializing in liver cancer and related gastrointestinal malignancies. Holding a Ph.D. in Surgery and a Bachelor's in Medicine from Jilin University, Dr. Jiao combines clinical practice with translational research to enhance therapeutic strategies in hepatopancreatobiliary diseases. Dr. Jiao's academic influence is centered on the integration of clinical oncology with bioinformatics, aiming to uncover novel prognostic markers and improve patient outcomes through large-scale data mining. He is distinguished by his cross-disciplinary expertise, which spans surgical oncology, adverse drug event analysis, and computational biology, setting him apart in a field that increasingly demands both clinical precision and data-driven insight. Dr. Jiao has authored over 70 peer-reviewed publications as first or corresponding author in high-impact journals such as Scientific Reports, World Journal of Gastrointestinal Surgery, and Frontiers in Nutrition. His research has been cited extensively, contributing to a growing Google Scholar H-index. In addition to his publishing record, Dr. Jiao has delivered numerous invited talks at international academic conferences and symposia, further establishing his presence in the global research community. He has received recognition for his work in pharmacovigilance and hepatobiliary oncology, and is an active member of several professional societies, including the Chinese Medical Association and the Chinese Society of Clinical Oncology. Dr. Jiao has also made significant editorial contributions to the academic publishing ecosystem. He has peer-reviewed over 100 manuscripts for respected journals across the fields of oncology, pharmacology, and surgical sciences. Furthermore, he has written more than 10 invited editorials on topics ranging from artificial intelligence in surgery to immune checkpoint therapy in liver cancer, showcasing his role as a thought leader in these emerging areas. Looking forward, Dr. Jiao aims to advance precision medicine in hepatobiliary cancer through continued exploration of molecular biomarkers, real-world data analytics, and AI-enhanced decision-making. His long-term research goals include developing predictive models for treatment response and complications, as well as elucidating the mechanisms of tumor progression under hypoxic microenvironments. Dr. Jiao brings a comprehensive suite of professional skills to his work, including advanced problem-solving and data analysis, strong leadership and mentoring abilities, and excellent interpersonal communication. He is adept at managing multidisciplinary research teams, providing guidance to junior investigators, and fostering collaboration across clinical and academic departments. His strengths in active listening and strategic thinking have been instrumental in both patient care and scientific advancement. Outside of his professional commitments, Dr. Jiao enjoys hiking, photography, and traditional Chinese literature. These hobbies not only provide balance to his demanding career but also inspire creativity and resilience in his research pursuits.